BSIM Therapeutics obtains NP 4457 certification in Research, Development and Innovation (RDI) Management

20 September, 2019

Large sem t%c3%adtulo2

BSIM Therapeutics’ Research, Development and Innovation (RDI) system has been certified through the NP 4457:2007 standard. This Portuguese standard defines the requirements of an effective RDI system, with the major goal of helping organizations to define their RDI policy and to achieve their innovation goals. This certification covers all BSIM Therapeutics’ activities relating to “Research, Development and Innovation of novel therapeutic drugs for the treatment of neurodegenerative diseases”.

By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more